Cory Ross Trankle, MD
Cory Ross Trankle, MD
Virginia Commonwealth University
Verified email at vcuhealth.org
Title
Cited by
Cited by
Year
Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)
A Abbate, MC Kontos, NA Abouzaki, RD Melchior, C Thomas, ...
The American journal of cardiology 115 (3), 288-292, 2015
802015
Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
BW Van Tassell, J Canada, S Carbone, C Trankle, L Buckley, ...
Circulation: Heart Failure 10 (11), e004373, 2017
572017
Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study
BW Van Tassell, NA Abouzaki, CO Erdle, S Carbone, C Trankle, ...
Journal of cardiovascular pharmacology 67 (6), 544, 2016
492016
Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction
S Carbone, JM Canada, LF Buckley, CR Trankle, DL Dixon, R Buzzetti, ...
Journal of the American College of Cardiology 68 (22), 2487, 2016
292016
A review of PCSK9 inhibition and its effects beyond LDL receptors
DL Dixon, C Trankle, L Buckley, E Parod, S Carbone, BW Van Tassell, ...
Journal of clinical lipidology 10 (5), 1073-1080, 2016
292016
Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐HART2)
BW Van Tassell, LF Buckley, S Carbone, CR Trankle, JM Canada, ...
Clinical cardiology 40 (9), 626-632, 2017
282017
Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction
S Carbone, LF Buckley, CR Trankle, HE Billingsley, DL Dixon, AG Mauro, ...
JACC: Basic to Translational Science 2 (5), 513-525, 2017
252017
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction: Results From DHART2
BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ...
Circulation: Heart Failure 11 (8), e005036, 2018
172018
Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein
CR Trankle, JM Canada, L Cei, N Abouzaki, C Oddi-Erdle, D Kadariya, ...
The American journal of cardiology 122 (8), 1366-1370, 2018
162018
Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
LF Buckley, JM Canada, MG Del Buono, S Carbone, CR Trankle, ...
ESC heart failure 5 (2), 372-378, 2018
162018
Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study
BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ...
Clinical cardiology 41 (8), 1004-1008, 2018
132018
Mitochondrial membrane permeability inhibitors in acute myocardial infarction: still awaiting translation
C Trankle, CJ Thurber, S Toldo, A Abbate
JACC: Basic to Translational Science 1 (6), 524-535, 2016
132016
Usefulness of C-reactive protein plasma levels to predict exercise intolerance in patients with chronic systolic heart failure
JMN Canada, DT Fronk, LF Cei, S Carbone, CO Erdle, NA Abouzaki, ...
The American journal of cardiology 117 (1), 116-120, 2016
122016
Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up
DL Dixon, LF Buckley, CR Trankle, D Kadariya, A Abbate
Drug design, development and therapy 11, 2121, 2017
92017
Resolution of pericardial constriction with Anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis
A Schatz, C Trankle, A Yassen, C Chipko, M Rajab, N Abouzaki, A Abbate
International journal of cardiology 223, 215-216, 2016
92016
Canada JM, Dixon DL, Abouzaki N, Oddi-Erdle C, Biondi-Zoccai G, Arena R, Abbate A
BW Van Tassell, LF Buckley, S Carbone, CR Trankle
Interleukin-1 blockade in heart failure with preserved ejection fraction …, 0
9
Inhibiting the inflammatory injury after myocardial ischemia reperfusion with plasma-derived alpha-1 antitrypsin: a post hoc analysis of the VCU-α1RT study
NA Abouzaki, S Christopher, C Trankle, BW Van Tassell, S Carbone, ...
Journal of cardiovascular pharmacology 71 (6), 375, 2018
82018
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics
S Carbone, JM Canada, HE Billingsley, D Kadariya, DL Dixon, ...
Diabetes, Obesity and Metabolism 20 (8), 2014-2018, 2018
72018
Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction
C Trankle, JM Canada, L Buckley, S Carbone, D Dixon, R Arena, ...
ESC heart failure 4 (3), 351-355, 2017
72017
IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB/II pilot study
CR Trankle, JM Canada, D Kadariya, R Markley, HM De Chazal, J Pinson, ...
American journal of respiratory and critical care medicine 199 (3), 381-384, 2019
62019
The system can't perform the operation now. Try again later.
Articles 1–20